Mechanisms mediating the vesicant actions of sulfur mustard after cutaneous exposure

Toxicological Sciences

Volumn 114, Issue 1, 2009, Pages 5-19

  Shakarjian, Michael P ^a,b   Heck, Diane E ^a   Gray, Joshua P ^c   Sinko, Patrick J ^d   Gordon, Marion K ^d   Casillas, Robert P ^e   Heindel, Ned D ^f   Gerecke, Donald R ^d   Laskin, Debra L ^d   Laskin, Jeffrey D ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c United States Coast Gaurd Academy ^*  (United States)

^d RUTGERS UNIVERSITY   (United States)

^e BATTELLE MEMORIAL INSTITUTE   (United States)

^f LEHIGH UNIVERSITY   (United States)

Author keywords

Alkylating agents; Blistering; Dermatotoxicity; Skin; Sulfur mustard

Indexed keywords

ALKYLATING AGENT; CHEMICAL WARFARE AGENT; DNA; LIPID; MUSTARD GAS; PROTEIN;

BASEMENT MEMBRANE; BLISTER; CELL ADHESION; CELL DEATH; CELL INFILTRATION; CROSS LINKING; CYTOTOXICITY; ERYTHEMA; HEALING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; KERATINOCYTE; NONHUMAN; REVIEW; SKIN EDEMA; SKIN TOXICITY;

EID: 77951587000     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfp253     Document Type: Review

References (176)

1. Airola, K., Vaalamo, M., Reunala, T., and Saarialho-Kere, U. K. (1995). Enhanced expression of interstitial collagenase, stromelysin-1, and urokinas1 plasminogen activator in lesions of dermatitis herpetiformis. J. Invest. Dermatol. 105, 184-189.
2. Amano, S., Scott, I. C., Takahara, K., Koch, M., Champliaud, M. F., Gerecke, D. R., Keene, D. R., Hudson, D. L., Nishiyama, T., Lee, S., et al. (2000). Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. J. Biol. Chem. 275, 22728-22735.
3. Arroyo, C. M., Broomfield, C. A., and Hackley, B. E., Jr. (2001). The role of interleukin-6 (IL-6) in human sulfur mustard (HD) toxicology. Int. J. Toxicol. 20, 281-296.
4. Arroyo, C. M., Schafer, R. J., Kurt, E. M., Broomfield, C. A., and Carmichael, A. J. (2000). Response of normal human keratinocytes to sulfur mustard: Cytokine release. J. Appl. Toxicol. 20(Suppl. 1), S63-S72.
5. Atkins, K. B., Lodhi, I. J., Hurley, L. L., and Hinshaw, D. B. (2000). N-acetylcysteine and endothelial cell injury by sulfur mustard. J. Appl. Toxicol. 20(Suppl. 1), S125-S128.
6. Babin, M. C., Ricketts, K., Skvorak, J. P., Gazaway, M., Mitcheltree, L. W., and Casillas, R. P. (2000). Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J. Appl. Toxicol. 20(Suppl. 1), S141-S144.
7. Balali-Mood, M., and Hefazi, M. (2005). The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam. Clin. Pharmacol. 19, 297-315.
8. Bartek, M. J., LaBudde, J. A., and Maibach, H. I. (1972). Skin permeability in vivo: Comparison in rat, rabbit, pig and man. J. Invest. Dermatol. 58, 114-123.
9. Bartlett, P. D., and Swain, C. G. (1949). Kinetics of hydrolysis and displacement reactions of β,β'-dichlorodiethyl sulfide (mustard gas) and of β-chloro-β'-hydroxydiethyl sulfide (mustard chlorohydrin). J. Am. Chem. Soc. 71, 1406-1415.
10. Berkowitz, P., Diaz, L., Hall, R., and Rubenstein, D. (2008). Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin. J. Invest. Dermatol. 128, 738-740.
11. Blaha, M., Bowers, W., Jr, Kohl, J., DuBose, D., Walker, J., Alkhyyat, A., and Wong, G. (2000). Effects of CEES on inflammatory mediators, heat shock protein 70A, histology and ultrastructure in two skin models. J. Appl. Toxicol. 20(Suppl. 1), S101-S108.
12. Brimfield, A., Mancebo, A., Mason, R., Jiang, J., Siraki, A., and Novak, M. (2009). Free radical production from the interaction of 2-chloroethyl vesicants (mustard gas) with pyridine nucleotide-driven flavoprotein electron transport systems. Toxicol. Appl. Pharmacol. 234, 128-134.
13. Brinkley, F. B., Mershon, M. M., Yaverbaum, S., Doxzon, B. F., and Wade, J. V. (1989). The mouse ear model as an in vivo bioassay for the assessment of topical mustard (HD) injury. In 1989 Medical Defense Bioscience Review, 15-17 August 1989, Aberdeen Proving Ground, MD, pp. 595-602.
14. Brodsky, B., Erlanger-Rosengarten, A., Proscura, E., Shapira, E., and Wormser, U. (2008). From topical antidote against skin irritants to a novel counter-irritating and anti-inflammatory peptide. Toxicol. Appl. Pharmacol. 229, 342-350.
15. Calabresi, P., and Chabner, B. (1990). Antineoplastic Agents. In Goodman and Gilman's The Pharmacological Basis of Therapeutics (A. Gilman, T. Rall, A. Nies, and P. Taylor, Eds.), pp. 1209-1219. McGraw-Hill, New York.
16. Casillas, R. P., Kiser, R. C., Truxall, J. A., Singer, A. W., Shumaker, S. M., Niemuth, N. A., Ricketts, K. M., Mitcheltree, L. W., Castrejon, L. R., and Blank, J. A. (2000). Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J. Appl. Toxicol. 20(Suppl. 1), S145-S151.
17. Casillas, R. P., Mitcheltree, L. W., and Stemler, F. W. (1997). The mouse ear model of cutaneous sulfur mustard injury. Toxicol. Methods 7, 381-397.
18. Chakrabarti, A. K., Ray, P., Broomfield, C. A., and Ray, R. (1998). Purification and characterization of protease activated by sulfur mustard in normal human epidermal keratinocytes. Biochem. Pharmacol. 56, 467-472.
19. Chiarugi, P., and Giannoni, E. (2008). Anoikis: A necessary death program for anchorage-dependent cells. Biochem. Pharmacol. 76, 1352-1374.
20. Chiesman, W. (1944). Diagnosis and treatment of lesions due to vesicants. Br. Med. J. 2, 109-112.
21. Cowan, F. M., and Broomfield, C. A. (1993). Putative roles of inflammation in the dermatopathology of sulfur mustard. Cell Biol. Toxicol. 9, 201-213.
22. Dachir, S., Fishbeine, E., Meshulam, Y., Sahar, R., Chapman, S., Amir, A., and Kadar, T. (2004). Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID. J. Appl. Toxicol. 24, 107-113.
23. Dacre, J. C., and Goldman, M. (1996). Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol. Rev. 48, 289-326.
24. Dannenberg, A. M., Jr, Pula, P. J., Liu, L. H., Harada, S., Tanaka, F., Vogt, R. F., Jr., Kajiki, A., and Higuchi, K. (1985). Inflammatory mediators and modulators released in organ culture from rabbit skin lesions produced in vivo by sulfur mustard. I. Quantitative histopathology; PMN, basophil, and mononuclear cell survival; and unbound (serum) protein content. Am. J. Pathol. 121, 15-27.
25. Debouzy, J. C., Aous, S., Dabouis, V., Neveux, Y., and Gentilhomme, E. (2002). Phospholipid matrix as a target for sulfur mustard (HD): NMR study in model membrane systems. Cell Biol. Toxicol. 18, 397-408.
26. Despretz, M. (1822). Des composes triples du chlore. Ann. Chem. Phys. 21, 438.
27. Dillman, J. F., III, Hege, A. I., Phillips, C. S., Orzolek, L. D., Sylvester, A. J., Bossone,C., Henemyre-Harris, C., Kiser,R.C., Choi, Y. W., Schlager, J. J., etal. (2006). Microarray analysis of mouse ear tissue exposed to bis-(2-chloroethyl) sulfide: Gene expression profiles correlate with treatment efficacy and an established clinical endpoint. J. Pharmacol. Exp. Ther. 317, 76-87.
28. Dillman, J. F., III, McGary, K. L., and Schlager, J. J. (2003). Sulfur mustard induces the formation of keratin aggregates in human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 193, 228-236.
29. Dröge, W. (2002). Free radicals in the physiological control of cell function. Physiol. Rev. 82, 47-95.
30. Easton, D. F., Peto, J., and Doll, R. (1988). Cancers of the respiratory tract in mustard gas workers. Br. J. Ind. Med. 45, 652-659.
31. Eldad, A., Ben Meir, P., Breiterman, S., Chaouat, M., Shafran, A., and Ben-Bassat, H. (1998). Superoxide dismutase (SOD) for mustard gas burns. Burns 24, 114-119.
32. Fox, M., and Scott, D. (1980). The genetic toxicology of nitrogen and sulphur mustard. Mutat. Res. 75, 131-168.
33. Frisch, S., and Screaton, R. (2001). Anoikis mechanisms. Curr. Opin. Cell Biol. 13, 555-562.
34. Frisch, S. M., and Francis, H. (1994). Disruption of epithelial cell-matrix interactions induces apoptosis. J. Cell Biol. 124, 619-626.
35. Fuchs, E. (1997). Keith R. Porter Lecture, 1996. Of mice and men: Genetic disorders of the cytoskeleton. Mol. Biol. Cell 8, 189-203.
36. Gentilhomme, E., Reano, A., Pradel, D., Bergier, J., Schmitt, D., and Neveux, Y. (1998). In vitro dermal intoxication by bis(chloroethyl)sulfide. Effect on secondary epidermization. Cell Biol. Toxicol. 14, 1-11.
37. Gerecke, D., Chen, M., Isukapalli, S., Gordon, M., Chang, Y., Tong, W., Androulakis, I., and Georgopoulos, P. (2009). Differential gene expression profiling of mouse skin after sulfur mustard exposure: Extended time response and inhibitor effect. Toxicol. Appl. Pharmacol. 234, 156-165.
38. Ghanei, M., Panahi, Y., Mojtahedzadeh, M., Khalili, A. R. H., and Aslani, J. (2006). Effect of gamma interferon on lung function of mustard gas exposed patients, after 15 years. Pulm. Pharmacol. Ther. 19, 148-153.
39. Ghosh, S., May, M. J., and Kopp, E. B. (1998). NF-jB AND REL PROTEINS: Evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16, 225-260.
40. Giancotti, F. G., and Tarone, G. (2003). Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu. Rev. Cell Dev. Biol. 19, 173-206.
41. Giannelli, G., Falk-Marzillier, J. O. S., Stetler-Stevenson, W. G., and Quaranta, V. (1997). Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277, 225-228.
42. Ginzler, A. M., and Davis, M. I. J. (1943). The pathology of mustard burns of human skin. U.S. Army Medical Research Laboratory, Edgewood Arsenal, MD.
43. Goldenberg, G., Vanstone, C., and Bihler, I. (1971). Transport of nitrogen mustard on the transport-carrier for choline in L5178Y lymphoblasts. Science 172, 1148-1149.
44. Goldenberg, G. J., and Begleiter, A. (1980). Membrane transport of alkylating agents. Pharmacol. Ther. 8, 237-274.
45. Greenberg, S., Kamath, P., Petrali, J., Hamilton, T., Garfield, J., and Garlick, J. A. (2006). Characterization of the initial response of engineered human skin to sulfur mustard. Toxicol. Sci. 90, 549-557.
46. Gross, C. L., Nealley, E. W., Nipwoda, M. T., and Smith, W. J. (2006). Pretreatment of human epidermal keratinocytes with D,L-sulforaphane protects against sulfur mustard cytotoxicity. Cutan. Ocul. Toxicol. 25, 155-163.
47. Guignabert, C., Taysse, L., Calvet, J. H., Planus, E., Delamanche, S., Galiacy, S., and d'Ortho, M. P. (2005). Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L67-L74.
48. Gunhan, O., Kurt, B., Karayilanoglu, T., Kenar, L., and Celasun, B. (2004). Morphological and immunohistochemical changes on rat skin exposed to nitrogen mustard. Mil. Med. 169, 7-10.
49. Guthrie, F. (1860). Uber einige Derivate der Kohlenwaserstoffe CnHn. Ann. Chem. Pharm. 113, 266-288.
50. Han, S., Espinoza, L. A., Liao, H., Boulares, A. H., and Smulson, M. E. (2004). Protection by antioxidants against toxicity and apoptosis induced by the sulphur mustard analog 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes. Br. J. Pharmacol. 141, 795-802.
51. Hayden, P., Petrali, J., Stolper, G., Hamilton, T., Jackson, G. J., Wertz, P., Ito, S., Smith, W., and Klausner, M. (2009). Microvesicating effects of sulfur mustard on an in vitro human skin model. Toxicol. In Vitro 23, 1396-1405.
52. Hayden, P. J., Petrali, J. P., Hamilton, T. A., Kubilus, J., Smith, W. J., and Klausner, M. (2005). Development of a full thickness in vitro human skin equivalent (Epiderm-FT) for sulfur mustard research. U.S. Army Medical Research Institute of Chemical Defense. Aberdeen Proving Ground, MD. Presented at Society of Investigative Dermatology, St. Louis, MO, 4-7 May, 2005.
53. Henriques, F. C., Jr, Moritz, A. R., Breyfogle, H. S., and Patterson, L. A. (1943). In The Mechanism of Cutaneous Injury by Mustard Gas. An Experimental Study Using Mustard Prepared with Radioactive Sulfur. Division 9, National Defense Research Committee of the Office of Scientific Research and Development, Washington, DC.
54. Hess, J. F., and FitzGerald, P. G. (2007). Treatment of keratin intermediate filaments with sulfur mustard analogs. Biochem. Biophys. Res. Commun. 359, 616-621.
55. Higuchi, K., Kajiki, A., Nakamura, M., Harada, S., Pula, P. J., Scott, A. L., and Dannenberg, A. M., Jr. (1988). Proteases released in organ culture by acute dermal inflammatory lesions produced in vivo in rabbit skin by sulfur mustard: Hydrolysis of synthetic peptide substrates for trypsin-like and chymotrypsin-like enzymes. Inflammation 12, 311-334.
56. Hinshaw, D. B., Lodhi, I. J., Hurley, L. L., Atkins, K. B., and Dabrowska, M. I. (1999). Activation of poly [ADP-ribose] polymerase in endothelial cells and keratinocytes: Role in an in vitro model of sulfur mustard-mediated vesication. Toxicol. Appl. Pharmacol. 156, 17-29.
57. Igoucheva, O., Kelly, A., Uitto, J., and Alexeev, V. (2007). Protein therapeutics for junctional epidermolysis bullosa: Incorporation of recombinant beta3 chain into laminin 332 in beta3-/-keratinocytes in vitro. J. Invest. Dermatol. 128, 1476-1486.
58. Inada, S., Hiragun, K., and Seo, K. (1978). Multiple Bowens disease observed in former workers of a poison gas factory in Japan with special reference to mustard gas exposure. J. Dermatol. 5, 49-60.
59. Ishida, H., Ray, R., and Ray, P. (2008). Sulfur mustard downregulates iNOS expression to inhibit wound healing in a human keratinocyte model. J. Dermatol Sci. 207-216.
60. Isidore, M., Castagna, M., Steele, K., Gordon, R., and Nambiar, M. (2007). A dorsal model for cutaneous vesicant injury by 2-chloroethyl ethyl sulfide using C57BL/6 mice. Cutan. Ocul. Toxicol. 26, 265-276.
61. Jin, X., Ray, R., Leng, Y., and Ray, P. (2008). Molecular determination of laminin-5 degradation: A biomarker for mustard gas exposure diagnosis and its mechanism of action. Exp. Dermatol. 17, 49-56.
62. Jin, X., Ray, R., Xu, G., and Ray, P. (2004). Studies on mustard-stimulated proteases and inhibitors in human epidermal keratinocytes (HEK): Development of antivesicant drugs. In Proceedings of the U.S. Army Medical Defense Bioscience Review, 16-21 May 2004, Hunt Valley, MD, pp. 1-10.
63. Jowsey, P., Williams, F., and Blain, P. (2009). DNA damage, signalling and repair after exposure of cells to the sulphur mustard analogue 2-chloroethyl ethyl sulphide. Toxicology 257, 105-112.
64. Kan, R. K., Pleva, C. M., Hamilton, T. A., Anderson, D. R., and Petrali, J. P. (2003). Sulfur mustard-induced apoptosis in hairless guinea pig skin. Toxicol. Pathol. 31, 185-190.
65. Kehe, K., Raithel, K., Kreppel, H., Jochum, M., Worek, F., and Thiermann, H. (2008). Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells. Arch. Toxicol. 82, 461-470.
66. Kehe, K., and Szinicz, L. (2005). Medical aspects of sulphur mustard poisoning. Toxicology 214, 198-209.
67. Khateri, S., Ghanei, M., Keshavarz, S., Soroush, M., and Haines, D. (2003). Incidence of lung, eye, and skin lesions as late complications in 34,000 Iranians withwartimeexposure tomustart agent. J. Occup. Environ. Med. 45, 1136-1143.
68. Klíma, J., Lacina, L., Dvořánková, B., Herrmann, D., Carnwath, J. W., Niemann, H., Kaltner, H., André, S., Motlík, J., Gabius, H. J., et al. (2008). Differential regulation of galectin expression/reactivity during wound healing in porcine skin and in cultures of epidermal cells with functional impact on migration. Physiol. Res. Advance Access published on June 2009.
69. Koch, P. J., Mahoney, M. G., Ishikawa, H., Pulkkinen, L., Uitto, J., Shultz, L., Murphy, G. F., Whitaker-Menezes, D., and Stanley, J. R. (1997). Targeted disruption of the pemphigus vulgaris antigen (desmoglein 3) gene in mice causes loss of keratinocyte cell adhesion with a phenotype similar to pemphigus vulgaris. J. Cell. Biol. 137, 1091-1102.
70. Kolodka, T. M., Garlick, J. A., and Taichman, L. B. (1998). Evidence for keratinocyte stem cells in vitro: Long term engraftment and persistence of transgene expression from retrovirus-transduced keratinocytes. Proc. Natl. Acad. Sci. U.S.A. 95, 4356-4361.
71. Koster, M. (2009). Making an epidermis. Ann. N. Y. Acad. Sci. 1170, 7-10.
72. Lefkowitz, L. J., and Smith, W. J. (2002). Sulfur mustard-induced arachidonic acid release is mediated by phospholipase D in human keratinocytes. Biochem. Biophys. Res. Commun. 295, 1062-1067.
73. Levitt, J. M., Vavra, A. K., Laurent, C. J., and Sweeney, J. F. (2004). The presence of polymorphonuclear leukocytes (PMN) affect the severity of sulfur mustard injury in the mouse ear model. In Proceedings of the U.S. Army Medical Defense Bioscience Review, 16-21 May 2004, Hunt Valley, MD, pp. 1-11.
74. Li, Y., Lin, X., Kilani, R., Jones, J., and Ghahary, A. (2007). 14-3-3 Sigma isoform interacts with the cytoplasmic domain of the transmembrane BP180 in keratinocytes. J. Cell. Physiol. 212, 675-681.
75. Lindsay, C. D., Hambrook, J. L., Brown, R. F., Platt, J. C., Knight, R., and Rice, P. (2004). Examination of changes in connective tissue macromolecular components of large white pig skin following application of Lewisite vapour. J. Appl. Toxicol. 24, 37-46.
76. Lindsay, C. D., and Rice, P. (1995). Changes in connective tissue macromolecular components of Yucatan mini-pig skin following application of sulphur mustard vapour. Hum. Exp. Toxicol. 14, 341-348.
77. Lindsay, C. D., and Rice, P. (1996). Assessment of the biochemical effects of percutaneous exposure of sulphur mustard in an in vitro human skin system. Hum. Exp. Toxicol. 15, 237-244.
78. Liu, Z., Li, N., Diaz, L. A., Shipley, M., Senior, R. M., and Werb, Z. (2005). Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J. Clin. Invest. 115, 879-887.
79. Liu, Z., Shipley, J. M., Vu, T. H., Zhou, X., Diaz, L. A., Werb, Z., and Senior, R. M. (1998). Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med. 188, 475-482.
80. Liu, Z., Zhou, X., Shapiro, S. D., Shipley, J. M., Twining, S. S., Diaz, L. A., Senior, R. M., and Werb, Z. (2000). The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 102, 647-655.
81. Malemud, C. J. (2006). Matrix metalloproteinases (MMPs) in health and disease: An overview. Front. Biosci. 11, 1696-1701.
82. Matijasevic, Z., and Volkert, M. R. (2007). Base excision repair sensitizes cells to sulfur mustard and chloroethyl ethyl sulfide. DNA Repair 6, 733-741.
83. McClintock, S. D., Till, G. O., Smith, M. G., and Ward, P. A. (2002). Protection from half-mustard-gas-induced acute lung injury in the rat. J. Appl. Toxicol. 22, 257-262.
84. Mehzad, M. (1988). Pathological study of skin lesions in chemical casualties. In First International Medical Congress on Chemical Warfare Agents in Iran, 13-16 June 1988, Mashhad, Iran.
85. Meyer, V. (1886). Ueber thiodiglykolverbindungen. Ber. d. Dtsch. Chem. Ges. 19, 3259-3266.
86. Mi, L., Gong, W., Nelson, P., Martin, L., and Sawyer, T. W. (2003). Hypothermia reduces sulphur mustard toxicity. Toxicol. Appl. Pharmacol. 193, 73-83.
87. Millard, C. B., Bongiovanni, R., and Broomfield, C. A. (1997). Cutaneous exposure to bis-(2-chloroethyl)sulfide results in neutrophil infiltration and increased solubility of 180,000 Mr subepidermal collagens. Biochem. Pharmacol. 53, 1405-1412.
88. Minsavage, G. D., and Dillman, J. F. I. (2007). Bifunctional alkylating agent-induced p53 and nonclassical nuclear factor-kappa B (NF-{kappa}B) responses and cell death are altered by caffeic acid phenethyl ester (CAPE): A potential role for antioxidant/electrophilic response element (ARE/EpRE) signaling. J. Pharmacol. Exp. Ther. 321, 202-212.
89. Mol, M. A., van den Berg, R. M., and Benschop, H. P. (2008). Proteomic assessment of sulfur mustard-induced protein adducts and other protein modifications in human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 230, 97-108.
90. Mol, M. A., van den Berg, R. M., and Benschop, H. P. (2009). Involvement of caspases and transmembrane metalloproteases in sulphur mustard-induced microvesication in adult human skin in organ culture: Directions for therapy. Toxicology 258, 39-46.
91. Monteiro-Riviere, N. A., and Inman, A. O. (1995). Indirect immunohisto-chemistry and immunoelectron microscopy distribution of eight epidermaldermal junction epitopes in the pig and in isolated perfused skin treated with bis(2-chloroethyl) sulfide. Toxicol. Pathol. 23, 313-325.
92. Monteiro-Riviere, N. A., and Inman, A. O. (1997). Ultrastructural characterization of sulfur mustard-induced vesication in isolated perfused porcine skin. Microsc. Res. Tech. 37, 229-241.
93. Monteiro-Riviere, N. A., Inman, A. O., Babin, M. C., and Casillas, R. P. (1999). Immunohistochemical characterization of the basement membrane epitopes in bis (2-chloroethyl) sulfide-induced toxicity in mouse ear skin. J. Appl. Toxicol. 19, 313-328.
94. Monteiro-Riviere, N. A., and Riviere, J. E. (1996). The pig as a model for cutaneous pharmacology and toxicology research. Cutan. Pharmacol. Toxicol. Res. 38, 425-458.
95. Mustargen-Merck. (2002). Physicians' Desk Reference. Thomson Medical Economics, Montvale, NJ.
96. Mydel, P., Shipley, J. M., Adair-Kirk, T. L., Kelley, D. G., Broekelmann, T. J., Mecham, R. P., and Senior, R. M. (2008). Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are chemotactic for neutrophils. J. Biol. Chem. 283, 9513-9522.
97. Nicotera, P., and Melino, G. (2004). Regulation of the apoptosis-necrosis switch. Oncogene 23, 2757-2765.
98. Niemann, A. (1860). Ueber die einwirkung des brauen chlorschwefels auf elaygas. Ann. d. Chem. u. Pharm. 113, 288-292.
99. Noort, D., Benschop, H. P., and Black, R. M. (2002). Biomonitoring of exposure to chemical warfare agents: A review. Toxicol. Appl. Pharmacol. 184, 116-126.
100. Nyska, A., Lomnitski, L., Maronpot, R., Moomaw, C., Brodsky, B., Sintov, A., and Wormser, U. (2001). Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin. Arch. Toxicol. 74, 768-774.
101. Oikarinen, A. I., Zone, J. J., Ahmed, A. R., Kiistala, U., and Uitto, J. (1983). Demonstration of collagenase and elastase activities in the blister fluids from bullous skin diseases. Comparison between dermatitis herpetiformis and bullous pemphigoid. J. Invest. Dermatol. 81, 261-266.
102. Pal, A., Tewari-Singh, N., Gu, M., Agarwal, C., Huang, J., Day, B. J., White, C. W., and Agarwal, R. (2009). Sulfur mustard analog induces oxidative stress and activates signaling cascades in the skin of SKH-1 hairless mice. Free Radic. Biol. Med. 47, 1640-1651.
103. Papirmeister, B., Feister, A. J., Robinson, S. I., and Ford, R. D. (1991). In Medical Defense against Mustard Gas: Toxic Mechanisms and Pharmacological Implications. CRC Press, Boca Raton, FL.
104. Papirmeister, B., Gross, C. L., Meier, H. L., Petrali, J. P., and Johnson, J. B. (1985). Molecular basis for mustard-induced vesication. Fundam. Appl. Toxicol. 5, S134-S149.
105. Papirmeister, B., Gross, C. L., and Petrali, J. P. (1984). Pathology produced by sulfur mustard in human skin grafts on athymic nude mice: 2. Ultastructural changes. J. Toxicol. Cutaneous Ocul. Toxicol. 3, 393-408.
106. Pappenheimer, A. M. (1926). Medical aspects of gas warfare. In The Medical Department of the United States Army in the World War (C. Lynch, Ed.). U.S. Government Printing Office, Washington, DC.
107. Paromov, V., Suntres, Z., Smith, M., and Stone, W. L. (2007). Sulfur mustard toxicity following dermal exposure: Role of oxidative stress and antioxidant therapy. J. Burns Wounds 7, e7.
108. Pechura C. M., and Rall, D. P., Eds. (1993). Veterans At Risk: The Health Effects of Mustard Gas and Lewisite. National Academy Press, Washington, DC.
109. Petit-Frère, C., Capulas, E., Lyon, D., Norbury, C., Lowe, J., Clingen, P., Riballo, E., Green, M., and Arlett, C. (2000). Apoptosis and cytokine release induced by ionizing or ultraviolet B radiation in primary and immortalized human keratinocytes. Carcinogenesis 1087-1095.
110. Pino, M. A., Hardej, D., and Billack, B. (2007). Mechlorethamine toxicity in skin cells is inhibited by butylated hydroxyanisole. The Toxicologist. 96, 33, 25-27 March 2007.
111. Powers, J. C., Kam, C. M., Ricketts, K. M., and Casillas, R. P. (2000). Cutaneous protease activity in the mouse ear vesicant model. J. Appl. Toxicol. 20(Suppl. 1), S177-S182.
112. Price, J., Rogers, J., McDougal, J., Shaw, M., Reid, F., and Graham, J. (2009). Transcriptional changes in porcine skin at 7 days following sulfur mustard and thermal burn injury. Cutan. Ocul. Toxicol. 28, 129-140.
113. Prussin, C., and Metcalfe, D. D. (2006). IgE, mast cells, basophils, and eosinophils. J. Allergy Clin. Immunol. 117, S450-S456.
114. Pulkkinen, L., Rouan, F., Bruckner-Tuderman, L., Wallerstein, R., Garzon, M., Brown, T., Smith, L., Carter, W., and Uitto, J. (1998). Novel ITGB4 mutations in lethal and nonlethal variants of epidermolysis bullosa with pyloric atresia: Missense versus nonsense. Am. J. Hum. Genet. 63, 1376-1387.
115. Rebholz, B., Kehe, K., Ruzicka, T., and Rupec, R. (2008). Role of NF-kappaB/RelA and MAPK pathways in keratinocytes in response to sulfur mustard. J. Invest. Dermatol. 128, 1626-1632.
116. Renshaw, B. (1946). Mechanisms in production of cutaneous injuries by sulfur and nitrogen mustards. In Chemical Warfare Agents and Related Chemical Problems U.S. Office of Scientific Research and Development, National Defense Research Commmittee Washington, DC, 479-518
117. Requena, L., Requena, C., Sanchez, M., Jaqueti, G., Aguilar, A., Sanchez-Yus, E., and Hernandez-Moro, B. (1988). Chemical warfare. Cutaneous lesions from mustard gas. J. Am. Acad. Dermatol. 19, 529-536.
118. Ricketts, K. M., Santai, C. T., France, J. A., Graziosi, A. M., Doyel, T. D., Gazaway, M. Y., and Casillas, R. P. (2000). Inflammatory cytokine response in sulfur mustard-exposed mouse skin. J. Appl. Toxicol. 20(Suppl. 1), S73-S76.
119. Ries, C., Popp, T., Egea, V., Kehe, K., and Jochum, M. (2008). Matrix metalloproteinase-9 expression and release from skin fibroblasts interacting with keratinocytes: Upregulation in response to sulphur mustard. Toxicology 263, 26-31.
120. Rikimaru, T., Nakamura, M., Yano, T., Beck, G., Habicht, G. S., Rennie, L. L., Widra, M., Hirshman, C. A., Boulay, M. G., Spannhake, E. W., et al. (1991). Mediators, initiating the inflammatory response, released in organ culture by full-thickness human skin explants exposed to the irritant, sulfur mustard. J. Invest. Dermatol. 96, 888-897.
121. Rogers, J., Choi, Y., Kiser, R., Babin, M., Casillas, R., Schlager, J., and Sabourin, C. (2004). Microarray analysis of gene expression in murine skin exposed to sulfur mustard. J. Biochem. Mol. Toxicol. 18, 289-299.
122. Rogers, J., McDougal, J., Price, J., Reid, F., and Graham, J. (2008). Transcriptional responses associated with sulfur mustard and thermal burns in porcine skin. Cutan. Ocul. Toxicol. 27, 135-160.
123. Rosenthal, D. S., Simbulan-Rosenthal, C. M., Iyer, S., Smith, W. J., Ray, R., and Smulson, M. E. (2000). Calmodulin, poly(ADP-ribose) polymerase and p53 are targets for modulating the effects of sulfur mustard. J. Appl. Toxicol. 20(Suppl. 1), S43-S49.
124. Rosenthal, D. S., Simbulan-Rosenthal, C. M., Iyer, S., Spoonde, A., Smith, W., Ray, R., and Smulson, M. E. (1998). Sulfur mustard induces markers of terminal differentiation and apoptosis in keratinocytes via a Ca2+-calmodulin and caspase-dependent pathway. J. Invest. Dermatol. 111, 64-71.
125. Rosenthal, D. S., Simbulan-Rosenthal, C. M., Liu, W. F., Velena, A., Anderson, D., Benton, B., Wang, Z. Q., Smith, W., Ray, R., and Smulson, M. E. (2001). PARP determines the mode of cell death in skin fibroblasts, but not keratinocytes, exposed to sulfur mustard. J. Invest. Dermatol. 117, 1566-1573.
126. Rosenthal, D. S., Velena, A., Chou, F. P., Schlegel, R., Ray, R., Benton, B., Anderson, D., Smith, W. J., and Simbulan-Rosenthal, C. M. (2003). Expression of dominant-negative Fas-associated death domain blocks human keratinocyte apoptosis and vesication induced by sulfur mustard. J. Biol. Chem. 278, 8531-8540.
127. Sabourin, C. L. K., Danne, M. M., Buxton, K. L., Casillas, R. P., and Schlager, J. J. (2002). Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J. Biochem. Mol. Toxicol. 16, 263-272.
128. Sabourin, C. L. K., Danne, M. M., Buxton, K. L., Rogers, J. V., Niemuth, N. A., Blank, J. A., Babin, M. C., and Casillas, R. P. (2003). Modulation of sulfur mustard-induced inflammation and gene expression by olvanil in the hairless mouse vesicant model. J. Toxicol. Cutaneous Ocul. Toxicol. 22, 125-136.
129. Sabourin, C. L. K., Petrali, J. P., and Casillas, R. P. (2000). Alterations in inflammatory cytokine gene expression in sulfur mustard-exposed mouse skin. J. Biochem. Mol. Toxicol. 14, 291-302.
130. Sadowski, T., Dietrich, S., Koschinsky, F., Ludwig, A., Proksch, E., Titz, B., and Sedlacek, R. (2005). Matrix metalloproteinase 19 processes the laminin 5 gamma 2 chain and induces epithelial cell migration. Cell. Mol. Life Sci. 62, 870-880.
131. Sawyer, T. W., Nelson, P., Hill, I., Conley, J. D., Blohm, K., Davidson, C., and Sawyer, T. W. (2002). Therapeutic effects of cooling swine skin exposed to sulfur mustard. Mil. Med. 167, 939-943.
132. Sawyer, T. W., and Risk, D. (1999). Effect of lowered temperature on the toxicity of sulphur mustard in vitro and in vivo. Toxicology 134, 27-37.
133. Schneider, H., Mühle, C., and Pacho, F. (2006). Biological function of laminin-5 and pathogenic impact of its deficiency. Eur. J. Cell Biol. 86, 701-717.
134. Shakarjian, M. P., Ajibade, D. V., Black, A. T., Chang, Y.-C., Gordon, M. K., Heck, D. E., Laskin, J. D., Riley, D. J., and Gerecke, D. R. (2007). Nitrogen mustard - induced alterations of matrix metalloproteinase-9 in mouse keratinocytes. Toxicologist 96, 158.
135. Shakarjian, M. P., Bhatt, P., Gordon, M. K., Chang, Y. C., Casbohm, S. L., Rudge, T. L., Kiser, R. C., Sabourin, C. L. K., Casillas, R. P., Ohman-Strickland, P., et al. (2006). Preferential expression of matrix metalloproteinase-9 in mouse skin after sulfur mustard exposure. J. Appl. Toxicol. 26, 239-246.
136. Shakarjian, M. P., Vetrano, A. M., Gray, J. P., DeSantis, A. S., Riley, D. J., Laskin, J. D., Chang, Y.-C., Gerecke, D. R., and Heck, D. E. (2008). Cell adhesion and migration changes in response to alkylation of laminin-332. In Proceedings of the U.S. Army Medical Defense Bioscience Review. 1-6 June 2008, Hunt Valley, MD, p. A138.
137. Shall, S., and de Murcia, G. (2000). Poly(ADP-ribose) polymerase-1: What have we learned from the deficient mouse model? Mutat. Res. 460, 1-15.
138. Sharma, M., Vijayaraghavan, R., and Ganesan, K. (2008). Comparison of toxicity of selected mustard agents by percutaneous and subcutaneous routes. Indian J. Exp. Biol. 46, 822-830.
139. Shimanovich, I., Mihai, S., Oostingh, G. J., Ilenchuk, T. T., Brocker, E. B., Opdenakker, G., Zillikens, D., and Sitaru, C. (2004). Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J. Pathol. 204, 519-527.
140. Sidell, F. R., and Hurst, C. G. (1997). Long-term health effects of nerve agents and mustard. In Textbook of Military Medicine-Medical Aspects of Chemical and Biological Warfare (R. Zaitchuk and R. F. Bellamy, Eds.), pp. 229-246. Office of the Surgeon General, Department of the Army, Washington, DC.
141. Simbulan-Rosenthal, C. M., Ray, R., Benton, B., Soeda, E., Daher, A., Anderson, D., Smith, W. J., and Rosenthal, D. S. (2006). Calmodulin mediates sulfur mustard toxicity in human keratinocytes. Toxicology 227, 21-35.
142. Simpson, R., and Lindsay, C. D. (2005). Effect of sulphur mustard on human skin cell lines with differential agent sensitivity. J. Appl. Toxicol. 25, 115-128.
143. Smith, C. N., and Lindsay, C. D. (2001). Kojic acid reduces the cytotoxic effects of sulfur mustard on cultures containing human melanoma cells in vitro. J. Appl. Toxicol. 21, 435-440.
144. Smith, K. J. (1999). The prevention and treatment of cutaneous injury secondary to chemical warfare agents. Application of these finding to other dermatologic conditions and wound healing. Dermatol. Clin. 17, 41-60.
145. Smith, K. J., Casillas, R., Graham, J., Skelton, H. G., Stemler, F., and Hackley, B. E., Jr. (1997a). Histopathologic features seen with different animal models following cutaneous sulfur mustard exposure. J. Dermatol. Sci. 14, 126-135.
146. Smith, K. J., Graham, J. S., Hamilton, T. A., Skelton, H. G., Petrali, J. P., and Hurst, C. G. (1997b). Immunohistochemical studies of basement membrane proteins and proliferation and apoptosis markers in sulfur mustard induced cutaneous lesions in weanling pigs. J. Dermatol. Sci. 15, 173-182.
147. Smith, K. J., Graham, J. S., Moeller, R. B., Okerberg, C. V., Skelton, H., and Hurst, C. G. (1995). Histopathologic features seen in sulfur mustard induced cutaneous lesions in hairless guinea pigs. J. Cutan. Pathol. 22, 260-268.
148. Smith, K. J., Smith, W. J., Hamilton, T., Skelton, H. G., Graham, J. S., Okerberg, C., Moeller, R., and Hackley, B. E., Jr. (1998). Histopathologic and immunohistochemical features in human skin after exposure to nitrogen and sulfur mustard. Am. J. Dermatopathol. 20, 22-28.
149. Smith, W. J. (2009). Therapeutic options to treat sulfur mustard poisoning-The road ahead. Toxicology 263, 70-73.
150. Smith, W. J., Gross, C. L., Chan, P., and Meier, H. L. (1990). The use of human epidermal keratinocytes in culture as a model for studying the biochemical mechanisms of sulfur mustard toxicity. Cell Biol. Toxicol. 6, 285-291.
151. Steinritz, D., Elischer, A., Balszuweit, F., Gonder, S., Heinrich, A., Bloch, W., Thiermann, H., and Kehe, K. (2009). Sulphur mustard induces time-and concentration-dependent regulation of NO-synthesizing enzymes. Toxicol. Lett. 188, 263-269.
152. Szallasi, A., and Blumberg, P. M. (1999). Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol. Rev. 51, 159-212.
153. Tanaka, F., Dannenberg, A. M., Jr, Higuchi, K., Nakamura, M., Pula, P. J., Hugli, T. E., Discipio, R. G., and Kreutzer, D. L. (1997). Chemotactic factors released in culture by intact developing and healing skin lesions produced in rabbits by the irritant sulfur mustard. Inflammation 21, 251-267.
154. Tewari-Singh, N., Rana, S., Gu, M., Pal, A., Orlicky, D. J., White, C. W., and Agarwal, R. (2009). Inflammatory biomarkers of sulfur mustard analog 2-chloroethyl ethyl sulfide-induced skin injury in SKH-1 hairless mice. Toxicol. Sci. 108, 194-206.
155. Tsuruta, J., Sugisaki, K., Dannenberg, A. M., Jr, Yoshimura, T., Abe, Y., and Mounts, P. (1996). The cytokines NAP-1 (IL-8), MCP-1, IL-1 beta, and GRO in rabbit inflammatory skin lesions produced by the chemical irritant sulfur mustard. Inflammation 20, 293-318.
156. Veitch, D. P., Nokelainen, P., McGowan, K. A., Nguyen, T. T., Nguyen, N. E., Stephenson, R., Pappano, W. N., Keene, D. R., Spong, S. M., Greenspan, D. S., et al. (2003). Mammalian tolloid metalloproteinase, and not matrix metalloprotease 2 or membrane type 1 metalloprotease, processes laminin-5 in keratinocytes and skin. J. Biol. Chem. 278, 15661-15668.
157. Vijayaraghavan, R., Sugendran, K., Pant, S. C., Husain, K., and Malhotra, R. C. (1991). Dermal intoxication of mice with bis(2-chloroethyl)sulphide and the protective effect of flavonoids. Toxicology 69, 35-42.
158. Virág, L., Szabó, E., Bakondi, E., Bai, P., Gergely, P., Hunyadi, J., and Szabó, C. (2002). Nitric oxide-peroxynitrite-poly(ADP-ribose) polymerase pathway in the skin. Exp. Dermatol. 11, 189-202.
159. Vogt, R. F., Jr., Dannenberg, A. M., Jr, Schofield, B. H., Hynes, N. A., and Papirmeister, B. (1984). Pathogenesis of skin lesions caused by sulfur mustard. Fundam. Appl. Toxicol. 4, S71-S83.
160. Wada, S., Miyanishi, M., Nishimoto, Y., Kambe, S., and Miller, R. W. (1968). Mustard gas as a cause of respiratory neoplasia in man. Lancet 1, 1161-1163.
161. Walker, I. G. (1971). Intrastrand bifunctional alkylation of DNA in mammalian cells treated with mustard gas. Can. J. Biochem. 49, 332-336.
162. Warthin, A. S., and Weller, D. V. (1919). In The Medical Aspects of Mustard Gas Poisoning. C.V. Mosby Co., St Louis, MO.
163. Weiss, A., and Weiss, B. (1975). Carcinogenesis due to mustard gas exposure in man, important sign for therapy with alkylating agents. Dtsch. Med. Wochenschr. 100, 919-923.
164. Werrlein, R. J., and Madren-Whalley, J. S. (2000). Effects of sulfur mustard on the basal cell adhesion complex. J. Appl. Toxicol. 20(Suppl. 1), S115-S123.
165. Woessner, J. F., Jr., Dannenberg, A. M., Jr., Pula, P. J., Selzer, M. G., Ruppert, C.L., Higuchi, K.,Kajiki, A., Nakamura, M., Dahms, N. M., Kerr, J.S., et al. (1990). Extracellular collagenase, proteoglycanase and products of their activity, released in organ culture by intact dermal inflammatory lesions produced by sulfur mustard. J. Invest. Dermatol. 95, 717-726.
166. Wormser, U., Brodsky, B., Proscura, E., Foley, J. F., Jones, T., and Nyska, A. (2005). Involvement of tumor necrosis factor-alpha in sulfur mustard-induced skin lesion; effect of topical iodine. Arch. Toxicol. 79, 660-670.
167. Wormser, U., Langenbach, R., Peddada, S., Sintov, A., Brodsky, B., and Nyska, A. (2004). Reduced sulfur mustard-induced skin toxicity in cyclooxygenase-2 knockout and celecoxib-treated mice. Toxicol. Appl. Pharmacol. 200, 40-47.
168. Xu, X., Kawachi, Y., Nakamura, Y., Sakurai, H., Hirota, A., Banno, T., Takahashi, T., Roop, D., and Otsuka, F. (2004). Yin-yang 1 negatively regulates the differentiation-specific transcription of mouse loricrin gene in undifferentiated keratinocytes. J. Invest. Dermatol. 1120-1126.
169. Yanagida, J., Hozawa, S., Ishioka, S., Maeda, H., Takahashi, K., Oyama, T., Takaishi, M., Hakoda, M., Akiyama, M., and Yamakido, M. (1988). Somatic mutation in peripheral lymphocytes of former workers at the Okunojima poison gas factory. Jpn. J. Cancer Res. 79, 1276-1283.
170. Yancey, K. B. (2005). The pathophysiology of autoimmune blistering diseases. J. Clin. Invest. 115, 825-828.
171. Yourick, J. J., Dawson, J. S., and Mitcheltree, L. W. (1995). Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin. J. Appl. Toxicol. 15, 133-138.
172. Zenz, R., Eferl, R., Scheinecker, C., Redlich, K., Smolen, J., Schonthaler, H., Kenner, L., Tschachler, E., and Wagner, E. (2008). Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res. Ther. 10, 201-211.
173. Zhang, Z., and Monteiro-Riviere, N. A. (1997). Comparison of integrins in human skin, pig skin, and perfused skin: An in vitro skin toxicology model. J. Appl. Toxicol. 17, 247-253.
174. Zhang, Z., Peters, B. P., and Monteiro-Riviere, N. A. (1995a). Assessment of sulfur mustard interaction with basement membrane components. Cell Biol. Toxicol. 11, 89-101.
175. Zhang, Z., Riviere, J. E., and Monteiro-Riviere, N. A. (1995b). Evaluation of protective effects of sodium thiosulfate, cysteine, niacinamide and indomethacin on sulfur mustard-treated isolated perfused porcine skin. Chem. Biol. Interact. 96, 249-262.
176. Zimmermann, K. C., Bonzon, C., and Green, D. R. (2001). The machinery of programmed cell death. Pharmacol. Ther. 92, 57-70.